| Total Records (953) |
| Targets |
| C1 (90) |
C3 (172) |
| C5 (112) |
fH (51) |
| fB (23) |
fD (24) |
| fI (12) |
fP (6) |
| MASPs (12) |
CRs (72) |
| MCP (32) |
DAF (39) |
| Others (89) |
| Disease |
| Eye Disorder (36) |
Sepsis (10) |
| Renal Disease (4) |
Cancer (39) |
| Transplant (37) |
Alzheimer (11) |
| SLE (7) |
Arthritis (7) |
| Others (127) |
| Application |
| Inhibition (565) |
Activation (32) |
| Diagnosis (115) |
Adsorbent (10) |
| Production (41) |
Structure (7) |
| Novel Protein (32) |
Assay (105) |
| Others (63) |
| Entity Type |
| Chemical Molecule (151) |
| Peptide (43) |
Protein (363) |
| Antibody (147) |
Biomaterial (54) |
| Nucleic Acid (31) |
Others (30) |
| |
|
| Welcome to Complement Patent Database |
| Complement is an essential part of innate immune response. It interplays with diverse endogenous pathways and contributes to the maintenance of homeostasis,
modulation of adaptive immune responses and development of various pathology states. The fascinating potential of complement in therapeutics and other applications inspires emerging patent
publications. Thousands complement related innovations have been published on drug discovery, disease diagnosis and treatment, immunoassay, and other fields. The Lambris Lab therefore initiated "Complement
Patent Database" project, which stores all the complement related patents as well as applications. And all the innovations were classified based on their targets, diseases, applications and entity types
|
| |
| >> View the List << |
| |
 |
|